Post-HCT Cyclophosphamide Boosts Transplant Success

(MedPage Today) -- Increased access to allogeneic hematopoietic cell transplant (HCT) is feasible for patients who lack an HLA-matched donor with the use of post-transplant cyclophosphamide (PTCy), according to a prospective phase II study.
Use...